Biotechnology major Biocon gets USFDA approval for generic product - Business Insights

Breaking

Post Top Ad

Post Top Ad

Thursday, December 2, 2021

Biotechnology major Biocon gets USFDA approval for generic product

The product is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant Read more at: Source

No comments:

Post a Comment

Post Top Ad